Article Details
Retrieved on: 2022-12-05 16:22:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Optimized and developed by AstraZeneca, the monoclonal antibody combination called Evusheld is the first treatment to protect adults and children ...
Article found on: news.vanderbilt.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here